Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
26.14
+0.82 (3.24%)
At close: Sep 4, 2026, 4:00 PM EDT
26.14
0.00 (0.00%)
After-hours: Sep 4, 2026, 5:21 PM EDT

Nurix Therapeutics Balance Sheet

Millions USD. Fiscal year is Dec - Nov.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Equivalents
67.69246.9611054.6364.4780.51
Short-Term Investments
375.84345.98499.59233.28244.67215.21
Cash & Short-Term Investments
443.53592.94609.58287.91309.14295.72
Cash Growth
-8.70%-2.73%111.73%-6.87%4.54%5.18%
Accounts Receivable
-----6
Other Receivables
1.91.51.50.81.11.1
Receivables
1.91.51.50.81.17.1
Prepaid Expenses
11.0512.388.36.88.218.29
Total Current Assets
456.48606.82619.39295.5318.45311.12
Property, Plant & Equipment
70.1173.0145.947.9529.5125.35
Long-Term Investments
---7.4263.88137.19
Long-Term Deferred Charges
-0.10.10.50.50.5
Other Long-Term Assets
8.958.213.964.224.422.62
Total Assets
535.54688.14669.34355.6416.76476.77

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Accounts Payable
12.2111.2211.486.45.066.65
Accrued Expenses
41.7251.734.4824.1920.8413.82
Current Portion of Leases
3.222.828.017.495.533.85
Current Income Taxes Payable
0.251.061.240.030.090.08
Current Unearned Revenue
13.3217.5838.3648.137.6341.21
Other Current Liabilities
1.32.12.280.751.50.66
Total Current Liabilities
72.0286.4795.8586.9670.6666.26
Long-Term Leases
54.9252.9120.2923.136.439.19
Long-Term Unearned Revenue
5.9710.0126.2145.0235.9759.02
Total Liabilities
132.91149.39142.35155.11113.06134.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Common Stock
0.10.10.080.050.050.05
Additional Paid-In Capital
1,5831,5421,266746.3709.22563.76
Retained Earnings
-1,180-1,003-738.77-545.2-401.25-220.89
Comprehensive Income & Other
-0.150.110.15-0.66-4.32-0.61
Total Common Equity
402.63538.75526.99200.49303.7342.3
Shareholders' Equity
402.63538.75526.99200.49303.7342.3
Total Liabilities & Equity
535.54688.14669.34355.6416.76476.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Total Debt
58.1455.7328.330.6111.9613.04
Net Cash (Debt)
385.39537.21581.28264.72361.06419.87
Net Cash Growth
-11.17%-7.58%119.59%-26.68%-14.01%49.34%
Net Cash Per Share
3.856.208.664.877.439.79
Filing Date Shares Outstanding
103.78102.8475.8948.8947.2744.74
Total Common Shares Outstanding
103.7101.8175.8748.7247.1744.66
Working Capital
384.46520.35523.53208.55247.79244.86
Book Value Per Share
3.885.296.954.126.447.66
Tangible Book Value
402.63538.75526.99200.49303.7342.3
Tangible Book Value Per Share
3.885.296.954.126.447.66
Machinery
44.4744.7541.0433.8327.6219.3
Leasehold Improvements
10.789.375.143.243.833.08
SEC Filings: 10-K · 10-Q